{"transactions":[{"id":2807359,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-06T01:04:17.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":5518,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5518,"derivative":{"exercise_price":87.11,"exercise_date":"2022-03-03","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":5518},"source":{"system":"sec-edgar","filing":"0001209191-21-018418","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018418/doc4.xml","form_type":"4"}},{"id":2807358,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-06T01:04:17.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":2726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 3, 2022."}],"balance_after":7913,"source":{"system":"sec-edgar","filing":"0001209191-21-018418","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018418/doc4.xml","form_type":"4"}},{"id":3004992,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2020-10-16T15:51:19.000Z","date":"2020-10-14","kind":"exercise","acquired":false,"price":0,"reported_value":3314963.25,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The convertible promissory note automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Nexus Development PA, LLC (\"Nexus\"). Dr. Martin currently serves as the President of Nexus. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":16.15,"expiration_date":"2022-02-20","underlying":"Common Stock","underlying_shares":205260},"source":{"system":"sec-edgar","filing":"0001209191-20-055042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1190578/000120919120055042/doc4.xml","form_type":"4"}},{"id":3004991,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-10-16T15:51:19.000Z","date":"2020-10-14","kind":"exercise","acquired":false,"shares":717509,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock and Series A Preferred Stock (the \"Preferred Stock\") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock and Series A Preferred Stock (the \"Preferred Stock\") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock and Series A Preferred Stock (the \"Preferred Stock\") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock and Series A Preferred Stock (the \"Preferred Stock\") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Nexus Development PA, LLC (\"Nexus\"). Dr. Martin currently serves as the President of Nexus. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":756971},"source":{"system":"sec-edgar","filing":"0001209191-20-055042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1190578/000120919120055042/doc4.xml","form_type":"4"}},{"id":3004990,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series Seed Preferred Stock","published_at":"2020-10-16T15:51:19.000Z","date":"2020-10-14","kind":"exercise","acquired":false,"shares":866667,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series Seed Preferred Stock and Series A Preferred Stock (the \"Preferred Stock\") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock and Series A Preferred Stock (the \"Preferred Stock\") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series Seed Preferred Stock and Series A Preferred Stock (the \"Preferred Stock\") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series Seed Preferred Stock and Series A Preferred Stock (the \"Preferred Stock\") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Nexus Development PA, LLC (\"Nexus\"). Dr. Martin currently serves as the President of Nexus. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":914333},"source":{"system":"sec-edgar","filing":"0001209191-20-055042","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1190578/000120919120055042/doc4.xml","form_type":"4"}},{"id":3004989,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T15:51:19.000Z","date":"2020-10-14","kind":"purchase","acquired":true,"shares":75800,"price":19,"value":1440200.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Nexus Development PA, LLC (\"Nexus\"). Dr. Martin currently serves as the President of Nexus. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1952364,"source":{"system":"sec-edgar","filing":"0001209191-20-055042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1190578/000120919120055042/doc4.xml","form_type":"4"}},{"id":3004988,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T15:51:19.000Z","date":"2020-10-14","kind":"exercise","acquired":true,"shares":205260,"price":16.15,"value":3314949.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Nexus Development PA, LLC (\"Nexus\"). Dr. Martin currently serves as the President of Nexus. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1876564,"source":{"system":"sec-edgar","filing":"0001209191-20-055042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190578/000120919120055042/doc4.xml","form_type":"4"}},{"id":3004987,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T15:51:19.000Z","date":"2020-10-14","kind":"exercise","acquired":true,"shares":756971,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock and Series A Preferred Stock (the \"Preferred Stock\") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Nexus Development PA, LLC (\"Nexus\"). Dr. Martin currently serves as the President of Nexus. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":1671304,"source":{"system":"sec-edgar","filing":"0001209191-20-055042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190578/000120919120055042/doc4.xml","form_type":"4"}},{"id":3004986,"issuer":{"id":78257,"kind":"organization","name":"Kronos Bio, Inc.","symbol":"KRON"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T15:51:19.000Z","date":"2020-10-14","kind":"exercise","acquired":true,"shares":914333,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series Seed Preferred Stock and Series A Preferred Stock (the \"Preferred Stock\") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Nexus Development PA, LLC (\"Nexus\"). Dr. Martin currently serves as the President of Nexus. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose."}],"balance_after":914333,"source":{"system":"sec-edgar","filing":"0001209191-20-055042","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190578/000120919120055042/doc4.xml","form_type":"4"}},{"id":3242227,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-02-29T01:02:58.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":3685,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3685,"derivative":{"exercise_price":114.47,"exercise_date":"2021-02-28","expiration_date":"2020-02-28","underlying":"Common Stock","underlying_shares":3685},"source":{"system":"sec-edgar","filing":"0001209191-20-014229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014229/doc4.xml","form_type":"4"}},{"id":3242226,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-02-29T01:02:58.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":5528,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in three equal annual installments beginning February 28, 2021."}],"balance_after":5528,"derivative":{"exercise_price":114.47,"expiration_date":"2020-02-28","underlying":"Common Stock","underlying_shares":5528},"source":{"system":"sec-edgar","filing":"0001209191-20-014229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014229/doc4.xml","form_type":"4"}},{"id":3242225,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-29T01:02:58.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":2075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021."}],"balance_after":5187,"source":{"system":"sec-edgar","filing":"0001209191-20-014229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014229/doc4.xml","form_type":"4"}},{"id":3242224,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-29T01:02:58.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":3112,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning February 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs vest in three equal annual installments beginning February 28, 2021."}],"balance_after":3112,"source":{"system":"sec-edgar","filing":"0001209191-20-014229","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014229/doc4.xml","form_type":"4"}},{"id":408193,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-02-08T22:52:24.000Z","date":"2019-02-06","kind":"tax_withholding","acquired":false,"shares":13787,"price":68.75,"value":947856.25,"ownership":{"direct":true},"balance_after":2887225,"source":{"system":"sec-edgar","filing":"0001127602-19-004859","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004859/form4.xml","form_type":"4"}},{"id":408192,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-02-08T22:52:24.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":15505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2016. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":2901012,"source":{"system":"sec-edgar","filing":"0001127602-19-004859","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004859/form4.xml","form_type":"4"}},{"id":408191,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2019-02-08T22:52:24.000Z","date":"2019-02-06","kind":"grant","acquired":true,"shares":7745,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 2, 2017. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":2885507,"source":{"system":"sec-edgar","filing":"0001127602-19-004859","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760219004859/form4.xml","form_type":"4"}},{"id":410059,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-12-05T01:02:46.000Z","date":"2018-12-03","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option have a five year vesting schedule. 20% vest on the first anniversary of the date of the grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-035244","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218035244/form4.xml","form_type":"4"}},{"id":410058,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-12-05T01:02:46.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":200,"price":72.665,"value":14533.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Sale prices reported for the transactions reported here range from $72.59 to $72.74.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":2877762,"source":{"system":"sec-edgar","filing":"0001127602-18-035244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218035244/form4.xml","form_type":"4"}},{"id":410057,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-12-05T01:02:46.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":13958,"price":71.9498,"value":1004275.3084,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices reported for the transactions reported here range from $71.56 to $72.50.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":2877962,"source":{"system":"sec-edgar","filing":"0001127602-18-035244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218035244/form4.xml","form_type":"4"}},{"id":410056,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-12-05T01:02:46.000Z","date":"2018-12-03","kind":"sale","acquired":false,"shares":35842,"price":70.9048,"value":2541369.8416,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $70.55 to $71.55.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":2891920,"source":{"system":"sec-edgar","filing":"0001127602-18-035244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218035244/form4.xml","form_type":"4"}},{"id":410055,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-12-05T01:02:46.000Z","date":"2018-12-03","kind":"exercise","acquired":true,"shares":50000,"price":23.6,"value":1180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":2927762,"source":{"system":"sec-edgar","filing":"0001127602-18-035244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218035244/form4.xml","form_type":"4"}},{"id":410054,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-12-05T01:02:46.000Z","date":"2018-11-29","kind":"gift","acquired":false,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares gifted to charitable trust"}],"balance_after":2877762,"source":{"system":"sec-edgar","filing":"0001127602-18-035244","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218035244/form4.xml","form_type":"4"}},{"id":410957,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-11-06T00:45:22.000Z","date":"2018-11-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a five year vesting schedule. 20% vest on the first anniversary of the date of the grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":50000,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-032174","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218032174/form4.xml","form_type":"4"}},{"id":410956,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-06T00:45:22.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":13579,"price":70.1548,"value":952632.0292,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices reported for the transactions reported here range from $70.05 to $70.40.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3017762,"source":{"system":"sec-edgar","filing":"0001127602-18-032174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218032174/form4.xml","form_type":"4"}},{"id":410955,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-06T00:45:22.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":28421,"price":69.5308,"value":1976134.8668,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $68.04 to $70.04.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3031341,"source":{"system":"sec-edgar","filing":"0001127602-18-032174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218032174/form4.xml","form_type":"4"}},{"id":410954,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-06T00:45:22.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":8000,"price":68.6063,"value":548850.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $68.03 to $69.03.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3059762,"source":{"system":"sec-edgar","filing":"0001127602-18-032174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218032174/form4.xml","form_type":"4"}},{"id":410953,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-11-06T00:45:22.000Z","date":"2018-11-01","kind":"exercise","acquired":true,"shares":50000,"price":23.6,"value":1180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3067762,"source":{"system":"sec-edgar","filing":"0001127602-18-032174","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218032174/form4.xml","form_type":"4"}},{"id":411520,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-10-03T21:45:29.000Z","date":"2018-10-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a five year vesting schedule. 20% vest on the first anniversary of the date of the grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":100000,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-029453","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218029453/form4.xml","form_type":"4"}},{"id":411519,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-10-03T21:45:29.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":16670,"price":78.3355,"value":1305852.785,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $78.18 to $78.58.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3017762,"source":{"system":"sec-edgar","filing":"0001127602-18-029453","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218029453/form4.xml","form_type":"4"}},{"id":411518,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-10-03T21:45:29.000Z","date":"2018-10-01","kind":"sale","acquired":false,"shares":33330,"price":77.8985,"value":2596357.005,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $77.17 to $78.17.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3034432,"source":{"system":"sec-edgar","filing":"0001127602-18-029453","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218029453/form4.xml","form_type":"4"}},{"id":411517,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-10-03T21:45:29.000Z","date":"2018-10-01","kind":"exercise","acquired":true,"shares":50000,"price":23.6,"value":1180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3067762,"source":{"system":"sec-edgar","filing":"0001127602-18-029453","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218029453/form4.xml","form_type":"4"}},{"id":412075,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-09-06T21:24:52.000Z","date":"2018-09-04","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a five year vesting schedule. 20% vest on the first anniversary of the date of the grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":150000,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-026965","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218026965/form4.xml","form_type":"4"}},{"id":412074,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-06T21:24:52.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":2624,"price":74.9962,"value":196790.0288,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $74.68 to $75.63.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3017762,"source":{"system":"sec-edgar","filing":"0001127602-18-026965","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218026965/form4.xml","form_type":"4"}},{"id":412073,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-06T21:24:52.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":47376,"price":74.1144,"value":3511243.8144,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $73.66 to $74.66.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3020386,"source":{"system":"sec-edgar","filing":"0001127602-18-026965","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218026965/form4.xml","form_type":"4"}},{"id":412072,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-09-06T21:24:52.000Z","date":"2018-09-04","kind":"exercise","acquired":true,"shares":50000,"price":23.6,"value":1180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3067762,"source":{"system":"sec-edgar","filing":"0001127602-18-026965","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218026965/form4.xml","form_type":"4"}},{"id":412957,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-08-03T20:41:56.000Z","date":"2018-08-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a five year vesting schedule. 20% vest on the first anniversary of the date of the grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":200000,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-024609","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218024609/form4.xml","form_type":"4"}},{"id":412956,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-08-03T20:41:56.000Z","date":"2018-08-01","kind":"sale","acquired":false,"shares":50000,"price":77.853,"value":3892650.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $77.38 to $78.33.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3017762,"source":{"system":"sec-edgar","filing":"0001127602-18-024609","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218024609/form4.xml","form_type":"4"}},{"id":412955,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-08-03T20:41:56.000Z","date":"2018-08-01","kind":"exercise","acquired":true,"shares":50000,"price":23.6,"value":1180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3067762,"source":{"system":"sec-edgar","filing":"0001127602-18-024609","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218024609/form4.xml","form_type":"4"}},{"id":413644,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-07-06T00:00:24.000Z","date":"2018-07-02","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a five year vesting schedule. 20% vest on the first anniversary of the date of the grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":250000,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-022892","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218022892/form4.xml","form_type":"4"}},{"id":413643,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-07-06T00:00:24.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":300,"price":71.36,"value":21408.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $71.35 to $71.37.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3017762,"source":{"system":"sec-edgar","filing":"0001127602-18-022892","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218022892/form4.xml","form_type":"4"}},{"id":413642,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-07-06T00:00:24.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":49700,"price":70.8023,"value":3518874.31,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $70.34 to $71.32.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3018062,"source":{"system":"sec-edgar","filing":"0001127602-18-022892","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218022892/form4.xml","form_type":"4"}},{"id":413641,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-07-06T00:00:24.000Z","date":"2018-07-02","kind":"exercise","acquired":true,"shares":50000,"price":23.6,"value":1180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3067762,"source":{"system":"sec-edgar","filing":"0001127602-18-022892","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218022892/form4.xml","form_type":"4"}},{"id":414342,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-06-05T23:34:33.000Z","date":"2018-06-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option have a five year vesting schedule. 20% vest on the first anniversary of the date of the grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":300000,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-020081","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218020081/form4.xml","form_type":"4"}},{"id":414341,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-06-05T23:34:33.000Z","date":"2018-06-01","kind":"sale","acquired":false,"shares":50000,"price":68.1299,"value":3406495.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $67.62 to $68.42.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3017762,"source":{"system":"sec-edgar","filing":"0001127602-18-020081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218020081/form4.xml","form_type":"4"}},{"id":414340,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-06-05T23:34:33.000Z","date":"2018-06-01","kind":"exercise","acquired":true,"shares":50000,"price":23.6,"value":1180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3067762,"source":{"system":"sec-edgar","filing":"0001127602-18-020081","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218020081/form4.xml","form_type":"4"}},{"id":415029,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2018-05-11T23:16:43.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":2283,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock units will vest upon the earlier of May 9, 2019, or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":2593,"derivative":{"underlying":"Common Stock","underlying_shares":2283},"source":{"system":"sec-edgar","filing":"0001127602-18-017246","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218017246/form4.xml","form_type":"4"}},{"id":415028,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-05-11T23:16:43.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":9496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option vest on each three-month anniversary measured from May 9, 2018 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 9, 2019 or the day immediately preceding the next regular annual stockholders meeting."}],"balance_after":9496,"derivative":{"exercise_price":65.69,"expiration_date":"2028-05-09","underlying":"Common Stock","underlying_shares":9496},"source":{"system":"sec-edgar","filing":"0001127602-18-017246","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218017246/form4.xml","form_type":"4"}},{"id":415334,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-05-03T17:07:06.000Z","date":"2018-05-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":350000,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-016152","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218016152/form4.xml","form_type":"4"}},{"id":415333,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-03T17:07:06.000Z","date":"2018-05-01","kind":"sale","acquired":false,"shares":50000,"price":72.1932,"value":3609660.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $71.83 to $72.81.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3017762,"source":{"system":"sec-edgar","filing":"0001127602-18-016152","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218016152/form4.xml","form_type":"4"}},{"id":415332,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-05-03T17:07:06.000Z","date":"2018-05-01","kind":"exercise","acquired":true,"shares":50000,"price":23.6,"value":1180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3067762,"source":{"system":"sec-edgar","filing":"0001127602-18-016152","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218016152/form4.xml","form_type":"4"}},{"id":416040,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-04-04T23:34:46.000Z","date":"2018-04-02","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":400000,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-014146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218014146/form4.xml","form_type":"4"}},{"id":416039,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-04-04T23:34:46.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":700,"price":74.9771,"value":52483.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Sale prices reported for the transactions reported here range from $74.93 to $75.05.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3017762,"source":{"system":"sec-edgar","filing":"0001127602-18-014146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218014146/form4.xml","form_type":"4"}},{"id":416038,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-04-04T23:34:46.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":9962,"price":74.3291,"value":740466.4942,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices reported for the transactions reported here range from $73.92 to $74.90.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3018462,"source":{"system":"sec-edgar","filing":"0001127602-18-014146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218014146/form4.xml","form_type":"4"}},{"id":416037,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-04-04T23:34:46.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":13080,"price":73.3861,"value":959890.188,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $72.91 to $73.91.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3028424,"source":{"system":"sec-edgar","filing":"0001127602-18-014146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218014146/form4.xml","form_type":"4"}},{"id":416036,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-04-04T23:34:46.000Z","date":"2018-04-02","kind":"sale","acquired":false,"shares":26258,"price":72.5099,"value":1903964.9542,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $71.90 to $72.90.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3041504,"source":{"system":"sec-edgar","filing":"0001127602-18-014146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218014146/form4.xml","form_type":"4"}},{"id":416035,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-04-04T23:34:46.000Z","date":"2018-04-02","kind":"exercise","acquired":true,"shares":50000,"price":23.6,"value":1180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3067762,"source":{"system":"sec-edgar","filing":"0001127602-18-014146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218014146/form4.xml","form_type":"4"}},{"id":416869,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2018-03-13T22:08:29.000Z","date":"2018-03-09","kind":"grant","acquired":true,"shares":310,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the restricted stock units will vest in one year on the anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"100% of the restricted stock units will vest in one year on the anniversary date of the grant."}],"balance_after":310,"derivative":{"underlying":"Common Stock","underlying_shares":310},"source":{"system":"sec-edgar","filing":"0001127602-18-011451","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218011451/form4.xml","form_type":"4"}},{"id":416868,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-03-13T22:08:29.000Z","date":"2018-03-09","kind":"grant","acquired":true,"shares":1309,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest quarterly over the first year of service."}],"balance_after":1309,"derivative":{"exercise_price":80.72,"expiration_date":"2028-03-09","underlying":"Common Stock","underlying_shares":1309},"source":{"system":"sec-edgar","filing":"0001127602-18-011451","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218011451/form4.xml","form_type":"4"}},{"id":417424,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-03-05T23:54:28.000Z","date":"2018-03-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":450000,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-010230","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218010230/form4.xml","form_type":"4"}},{"id":417423,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-03-05T23:54:28.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":6523,"price":79.4913,"value":518521.7499,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices reported for the transactions reported here range from $79.36 to $79.74.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3017762,"source":{"system":"sec-edgar","filing":"0001127602-18-010230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218010230/form4.xml","form_type":"4"}},{"id":417422,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-03-05T23:54:28.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":26575,"price":78.9539,"value":2098199.8925,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $78.35 to $79.35.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3024285,"source":{"system":"sec-edgar","filing":"0001127602-18-010230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218010230/form4.xml","form_type":"4"}},{"id":417421,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-03-05T23:54:28.000Z","date":"2018-03-01","kind":"sale","acquired":false,"shares":16902,"price":77.8401,"value":1315653.3702,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $77.33 to $78.32.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3050860,"source":{"system":"sec-edgar","filing":"0001127602-18-010230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218010230/form4.xml","form_type":"4"}},{"id":417420,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-03-05T23:54:28.000Z","date":"2018-03-01","kind":"exercise","acquired":true,"shares":50000,"price":23.6,"value":1180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3067762,"source":{"system":"sec-edgar","filing":"0001127602-18-010230","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218010230/form4.xml","form_type":"4"}},{"id":418287,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-02-23T23:54:11.000Z","date":"2018-02-21","kind":"tax_withholding","acquired":false,"shares":19354,"price":80.69,"value":1561674.26,"ownership":{"direct":true},"balance_after":3017762,"source":{"system":"sec-edgar","filing":"0001127602-18-008137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008137/form4.xml","form_type":"4"}},{"id":418286,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-02-23T23:54:11.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":18630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2015. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors."}],"balance_after":3037116,"source":{"system":"sec-edgar","filing":"0001127602-18-008137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008137/form4.xml","form_type":"4"}},{"id":418285,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-02-23T23:54:11.000Z","date":"2018-02-21","kind":"grant","acquired":true,"shares":21380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 1, 2016, and February 16, 2017. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual satisfies the applicable service-vesting requirements by continuing in the Issuer's employ through December 31, 2018 and December 31, 2019, respectively."}],"balance_after":3018486,"source":{"system":"sec-edgar","filing":"0001127602-18-008137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008137/form4.xml","form_type":"4"}},{"id":418284,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-02-23T23:54:11.000Z","date":"2018-02-15","kind":"grant","acquired":true,"shares":340,"price":62.3475,"value":21198.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan."}],"balance_after":2997106,"source":{"system":"sec-edgar","filing":"0001127602-18-008137","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218008137/form4.xml","form_type":"4"}},{"id":419643,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-02-06T01:38:06.000Z","date":"2018-02-01","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":500000,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-004146","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218004146/form4.xml","form_type":"4"}},{"id":419642,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-02-06T01:38:06.000Z","date":"2018-02-01","kind":"sale","acquired":false,"shares":30723,"price":83.6873,"value":2571124.9179,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $83.55 to $84.12.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":2996766,"source":{"system":"sec-edgar","filing":"0001127602-18-004146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218004146/form4.xml","form_type":"4"}},{"id":419641,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-02-06T01:38:06.000Z","date":"2018-02-01","kind":"sale","acquired":false,"shares":19277,"price":83.348,"value":1606699.396,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $82.54 to $83.54.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3027489,"source":{"system":"sec-edgar","filing":"0001127602-18-004146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218004146/form4.xml","form_type":"4"}},{"id":419640,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-02-06T01:38:06.000Z","date":"2018-02-01","kind":"exercise","acquired":true,"shares":50000,"price":23.6,"value":1180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3046766,"source":{"system":"sec-edgar","filing":"0001127602-18-004146","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218004146/form4.xml","form_type":"4"}},{"id":420664,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2018-01-05T00:54:59.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":550000,"derivative":{"exercise_price":23.6,"expiration_date":"2019-01-21","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001127602-18-001216","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001216/form4.xml","form_type":"4"}},{"id":420663,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-01-05T00:54:59.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":18954,"price":73.9482,"value":1401614.1828,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices reported for the transactions reported here range from $73.80 to $74.21.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":2996766,"source":{"system":"sec-edgar","filing":"0001127602-18-001216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001216/form4.xml","form_type":"4"}},{"id":420662,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-01-05T00:54:59.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":26941,"price":73.6048,"value":1982986.9168,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $72.79 to $73.79.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3015720,"source":{"system":"sec-edgar","filing":"0001127602-18-001216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001216/form4.xml","form_type":"4"}},{"id":420661,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-01-05T00:54:59.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":4105,"price":72.2617,"value":296634.2785,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $71.74 to $72.73.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3042661,"source":{"system":"sec-edgar","filing":"0001127602-18-001216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001216/form4.xml","form_type":"4"}},{"id":420660,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2018-01-05T00:54:59.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":50000,"price":23.6,"value":1180000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3046766,"source":{"system":"sec-edgar","filing":"0001127602-18-001216","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760218001216/form4.xml","form_type":"4"}},{"id":421605,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-12-06T00:49:26.000Z","date":"2017-12-01","kind":"exercise","acquired":false,"shares":73333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":0,"derivative":{"exercise_price":21.575,"expiration_date":"2018-01-30","underlying":"Common Stock","underlying_shares":73333},"source":{"system":"sec-edgar","filing":"0001127602-17-033996","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217033996/form4.xml","form_type":"4"}},{"id":421604,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-12-06T00:49:26.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":12500,"price":74.3527,"value":929408.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $73.55 to $74.55.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":2996766,"source":{"system":"sec-edgar","filing":"0001127602-17-033996","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217033996/form4.xml","form_type":"4"}},{"id":421603,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-12-06T00:49:26.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":101,"price":75.5701,"value":7632.5801,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices for the transaction reported here range from $75.57 to $75.58. Full information regarding the number of shares purchased or sold at each seperate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3009266,"source":{"system":"sec-edgar","filing":"0001127602-17-033996","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217033996/form4.xml","form_type":"4"}},{"id":421602,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-12-06T00:49:26.000Z","date":"2017-12-01","kind":"sale","acquired":false,"shares":60732,"price":75.1061,"value":4561343.6652,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Sale prices reported for the transactions reported here range from $74.56 to $75.56.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3009367,"source":{"system":"sec-edgar","filing":"0001127602-17-033996","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217033996/form4.xml","form_type":"4"}},{"id":421601,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-12-06T00:49:26.000Z","date":"2017-12-01","kind":"exercise","acquired":true,"shares":73333,"price":21.575,"value":1582159.475,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3070099,"source":{"system":"sec-edgar","filing":"0001127602-17-033996","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217033996/form4.xml","form_type":"4"}},{"id":422515,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-11-03T23:04:20.000Z","date":"2017-11-01","kind":"exercise","acquired":false,"shares":73333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":73333,"derivative":{"exercise_price":21.575,"expiration_date":"2018-01-30","underlying":"Common Stock","underlying_shares":73333},"source":{"system":"sec-edgar","filing":"0001127602-17-031275","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031275/form4.xml","form_type":"4"}},{"id":422514,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-11-03T23:04:20.000Z","date":"2017-11-01","kind":"sale","acquired":false,"shares":7477,"price":75.6045,"value":565294.8465,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $75.47 to $75.81.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":2996766,"source":{"system":"sec-edgar","filing":"0001127602-17-031275","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031275/form4.xml","form_type":"4"}},{"id":422513,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-11-03T23:04:20.000Z","date":"2017-11-01","kind":"sale","acquired":false,"shares":65856,"price":75.079,"value":4944402.624,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $74.46 to $75.46.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3004243,"source":{"system":"sec-edgar","filing":"0001127602-17-031275","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031275/form4.xml","form_type":"4"}},{"id":422512,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-11-03T23:04:20.000Z","date":"2017-11-01","kind":"exercise","acquired":true,"shares":73333,"price":21.575,"value":1582159.475,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3070099,"source":{"system":"sec-edgar","filing":"0001127602-17-031275","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217031275/form4.xml","form_type":"4"}},{"id":423069,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-10-04T23:19:53.000Z","date":"2017-10-02","kind":"exercise","acquired":false,"shares":73333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":146666,"derivative":{"exercise_price":21.575,"expiration_date":"2018-01-30","underlying":"Common Stock","underlying_shares":73333},"source":{"system":"sec-edgar","filing":"0001127602-17-029284","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217029284/form4.xml","form_type":"4"}},{"id":423068,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-10-04T23:19:53.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":68133,"price":82.6157,"value":5628855.4881,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $82.27 to $82.92.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":2996766,"source":{"system":"sec-edgar","filing":"0001127602-17-029284","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217029284/form4.xml","form_type":"4"}},{"id":423067,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-10-04T23:19:53.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":5200,"price":81.82,"value":425464.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $81.26 to $82.25.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3064899,"source":{"system":"sec-edgar","filing":"0001127602-17-029284","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217029284/form4.xml","form_type":"4"}},{"id":423066,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-10-04T23:19:53.000Z","date":"2017-10-02","kind":"exercise","acquired":true,"shares":73333,"price":21.575,"value":1582159.475,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3070099,"source":{"system":"sec-edgar","filing":"0001127602-17-029284","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217029284/form4.xml","form_type":"4"}},{"id":423568,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-09-07T00:23:32.000Z","date":"2017-09-01","kind":"exercise","acquired":false,"shares":73333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":219999,"derivative":{"exercise_price":21.575,"expiration_date":"2018-01-30","underlying":"Common Stock","underlying_shares":73333},"source":{"system":"sec-edgar","filing":"0001127602-17-027110","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217027110/form4.xml","form_type":"4"}},{"id":423567,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-09-07T00:23:32.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":14995,"price":83.4341,"value":1251094.3295,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Sale prices reported for the transactions reported here range from $83.30 to $84.06.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":2996766,"source":{"system":"sec-edgar","filing":"0001127602-17-027110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217027110/form4.xml","form_type":"4"}},{"id":423566,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-09-07T00:23:32.000Z","date":"2017-09-01","kind":"sale","acquired":false,"shares":58338,"price":83.0316,"value":4843897.4808,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Sale prices reported for the transactions reported here range from $82.29 to $83.29.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3011761,"source":{"system":"sec-edgar","filing":"0001127602-17-027110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217027110/form4.xml","form_type":"4"}},{"id":423565,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-09-07T00:23:32.000Z","date":"2017-09-01","kind":"exercise","acquired":true,"shares":73333,"price":21.575,"value":1582159.475,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3070099,"source":{"system":"sec-edgar","filing":"0001127602-17-027110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217027110/form4.xml","form_type":"4"}},{"id":423564,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-09-07T00:23:32.000Z","date":"2017-08-31","kind":"gift","acquired":false,"shares":129870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares gifted to charitable trust"}],"balance_after":2996766,"source":{"system":"sec-edgar","filing":"0001127602-17-027110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217027110/form4.xml","form_type":"4"}},{"id":424352,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-08-03T22:55:21.000Z","date":"2017-08-01","kind":"exercise","acquired":false,"shares":73333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant. The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":293332,"derivative":{"exercise_price":21.575,"expiration_date":"2018-01-30","underlying":"Common Stock","underlying_shares":73333},"source":{"system":"sec-edgar","filing":"0001127602-17-024921","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217024921/form4.xml","form_type":"4"}},{"id":424351,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-08-03T22:55:21.000Z","date":"2017-08-01","kind":"sale","acquired":false,"shares":73333,"price":75.8564,"value":5562777.3812,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $75.53 to $76.35.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3126636,"source":{"system":"sec-edgar","filing":"0001127602-17-024921","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217024921/form4.xml","form_type":"4"}},{"id":424350,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-08-03T22:55:21.000Z","date":"2017-08-01","kind":"exercise","acquired":true,"shares":73333,"price":21.575,"value":1582159.475,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3199969,"source":{"system":"sec-edgar","filing":"0001127602-17-024921","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217024921/form4.xml","form_type":"4"}},{"id":424987,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Non-qualified Stock Option (Right to Buy)","published_at":"2017-07-06T22:38:44.000Z","date":"2017-07-03","kind":"exercise","acquired":false,"shares":73333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options have a five year vesting schedule. 20% vest on the first anniversary of the date of grant.  The balance will vest 5% quarterly thereafter until fully vested."}],"balance_after":366665,"derivative":{"exercise_price":21.575,"expiration_date":"2018-01-30","underlying":"Common Stock","underlying_shares":73333},"source":{"system":"sec-edgar","filing":"0001127602-17-023302","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217023302/form4.xml","form_type":"4"}},{"id":424986,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-07-06T22:38:44.000Z","date":"2017-07-03","kind":"sale","acquired":false,"shares":73333,"price":71.0034,"value":5206892.3322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Sale prices reported for the transactions reported here range from $70.57 to $71.56.  Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request."}],"balance_after":3126636,"source":{"system":"sec-edgar","filing":"0001127602-17-023302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217023302/form4.xml","form_type":"4"}},{"id":424985,"issuer":{"id":405,"kind":"organization","name":"GILEAD SCIENCES, INC.","symbol":"GILD"},"owners":[{"id":16028,"kind":"person","name":"MARTIN JOHN C","position":1,"cik":"0001190578","reported_name":"MARTIN JOHN C","relationship":{"director":true,"officer":true,"officer_title":"Executive Chairman"}}],"security":"Common Stock","published_at":"2017-07-06T22:38:44.000Z","date":"2017-07-03","kind":"exercise","acquired":true,"shares":73333,"price":21.575,"value":1582159.475,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan."}],"balance_after":3199969,"source":{"system":"sec-edgar","filing":"0001127602-17-023302","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882095/000112760217023302/form4.xml","form_type":"4"}}],"next_cursor":"2017-07-06T22:38:44.000000Z,424985"}